Nano Dimension’s Chairman & CEO Responds to the Latest
A Detailed Study of Anson’s Published Track Record......
Hyloris reports full year results for 2022 & provides
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for......